Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myositis and malignancy

J P Callen1

  • 1University of Louisville, Kentucky.

Current Opinion in Rheumatology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Dermatomyositis is linked to a higher cancer risk, particularly ovarian cancer in women, while polymyositis shows no significant increase. Malignancy screening should be guided by individual patient factors and age.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-C1q antibodies in systemic lupus erythematosus.

Lupus·2014
Same author

Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus.

Lupus·2011
Same author

Drug-induced subacute cutaneous lupus erythematosus.

Lupus·2010
Same author

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus.

Lupus·2004
Same author

Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.

Clinical and experimental dermatology·2004
Same author

Update on the management of cutaneous lupus erythematosus.

The British journal of dermatology·2004
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Rheumatology and Oncology
  • Autoimmune Myopathies
  • Paraneoplastic Syndromes

Background:

  • Dermatomyositis and polymyositis are idiopathic inflammatory myopathies.
  • An association between dermatomyositis and increased malignancy risk has been suggested.
  • The specific cancer risks and detection challenges in these conditions require clarification.

Purpose of the Study:

  • To evaluate the association between dermatomyositis and polymyositis and the risk of malignancy.
  • To identify specific cancer types potentially overrepresented in dermatomyositis patients.
  • To discuss the clinical approach for malignancy screening in patients with inflammatory myopathies.

Main Methods:

  • Review of existing literature and clinical data on dermatomyositis and polymyositis.

Related Experiment Videos

  • Analysis of reported frequencies of malignancy in patients with these conditions.
  • Evaluation of the characteristics of paraneoplastic courses and detection strategies.

    • Main Results:

    • Dermatomyositis demonstrates a significantly higher frequency of associated malignancy compared to the general population.
    • Polymyositis does not appear to carry a substantially increased risk of malignancy.
    • Ovarian cancer may be disproportionately represented in women with dermatomyositis and can be challenging to detect.

    Conclusions:

    • Patients with dermatomyositis have an elevated risk for developing cancer.
    • Malignancy screening in dermatomyositis should be individualized, considering age, symptoms, and clinical findings.
    • While paraneoplastic syndromes occur, they are not the typical presentation; proactive, age-appropriate cancer screening is crucial.